Analyst firms · H.C. Wainwright · HUMA

H.C. Wainwright HUMA price target and rating history

Humacyte Inc. (HUMA) · Health Care

H.C. Wainwright rates Humacyte Inc. (HUMA) Buy with a $4 price target, as of its latest action on May 14, 2025. It has published 3 rating actions on HUMA since December 2023, including 0 upgrades and 0 downgrades.

Current rating
Buy
Price target
$4
Median target, all firms
Too few
Actions on HUMA
3

H.C. Wainwright price target on HUMA

$15$9.50$4202420252026
H.C. Wainwright price target on HUMA, each point a stated target, December 2023 to May 2025. Targets before December 2024 (multiplied by 2) are adjusted for a stock split, going by the prior target H.C. Wainwright restated.

Every H.C. Wainwright rating on HUMA

Questions about H.C. Wainwright and HUMA

What is H.C. Wainwright's price target for HUMA?
H.C. Wainwright's latest stated price target for Humacyte Inc. (HUMA) is $4, from its action on May 14, 2025.
What is H.C. Wainwright's rating on HUMA?
H.C. Wainwright rates HUMA Buy, a bullish rating, as of May 14, 2025.
When did H.C. Wainwright last change its view on HUMA?
On May 14, 2025, H.C. Wainwright resumes coverage at Buy, price target $4.

More HUMA rating histories

All H.C. Wainwright ratingsHUMA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.